📌 And one more important release of the ending year - a new #OncoWiki chapter on #LiverCancer & #BiliaryCancer 🎗
Explore this easy-to-read resource for patients, caregivers, and non-oncological specialists here:

📚 wiki.nenaprasno.ru/nosologies/opu…

Image Credit: baltimoresun.com/2017/11/20/car…

Next up ⁦Grainne O’Kane Grainne O'Kane⁩ talk about #precisionmedicine for #pancreaticcancer #biliarycancer #OF23 ⁦Oncology Forum UK⁩

The eagerly awaited #PFS data for #TrastuzumabDeruxtecan in #BiliaryCancer presented in #ESMO23 by #FundaMericBernstam from the DESTINY-PanTumor02

➡️mPFS 7.4 months (IHC3+)👍🏻
[Previously reported ORR 56%]
📸#3

ESMO - Eur. Oncology

The International #Cholangiocarcinoma Research Network (ICRN) and Cholangiocarcinoma Foundation are enjoying hosting the 6th Annual Asia-Pacific Cholangiocarcinoma Conference in Mumbai, India.

An excellent opportunity to learn more about research advances, treatment, and #biliarycancer patient care.

Thank you, Tanios Bekaii-Saab, MD (@GIcancerdoc), Rachna Shroff, MD, MS, FASCO (@rachnatshroff), & Milind Javle, MD (@JavleMilind), our amazing faculty who delivered a fantastic #BiliaryCancer #MedEd ❗️

To view the replay please visit: bit.ly/BiliarySF24T
#MedTwitter Cholangiocarcinoma Foundation

Congrats to Manish A. Shah and Brandon Swed and Uqba Khan on their The ASCO Post articles at #GI24 . #esophagealcancer #biliarycancer #gallbladder #her2mutation WCM GI Cancer
way to represent Weill Cornell Medicine

IMbrave151 phase 2 study of gem/cis/atezo/bev vs. gem/cis/atezo/placebo in advanced #biliarycancer ➡️ improved PFS with bev HR 0.76, same ORR ~24%, possible OS benefit Anthony El-Khoueiry $GENE
#GI23 ASCO Cure GI Cancers OncoAlert

#BiliaryCancer (part 3/3) abstracts on display today in #ESMO23

My selection of the 4 pictures allowed in X here 📸

ESMO - Eur. Oncology

Remember to join us tonight, January 18th at 5:15 PM PST, for our #BiliaryCancer in-person & virtual symposium, and to tweet your questions in advance! As always, please be sure to follow PeerView for more #MedEd content! bit.ly/BiliarySF24T #GI24

💙 #ClinicalResearch and trials suggest that there is more hope in the fight against cancer. We emphasize the importance of #EarlyDiagnosis and say that there is always hope for everyone.

#BiliaryCancer #CancerTreatments #ClinicalTrials

Presenting our interim analysis of the US experience in second-line nanoliposomal irinotecan/5-FU/leucovorin in advanced #biliarycancer #WCGIC2023 #Barcelona World Congress on Gastrointestinal Cancer ESMO - Eur. Oncology Cure GI Cancers Anita Turk Ruth He, MD, PhD Marcus S. Noel John Marshall Katrina Pedersen, MD, MS Siteman Cancer Center

I’m so excited 🤩 it’s MDT debate time!! First debate is in #BiliaryCancer with superstar surgeons Prof Anubhav Mittal vs Prof Diane Simeone, with the case kindly presented by Dr Chris Lim 🥊 Do you do a Hepatopancreato-duodenectomy or a two stage approach??

#BiliaryCancer (part 2/3) abstracts on display today in #ESMO23

🧬MTAPloss
1-2.- look at prevalence in #BiliaryCancer
3.- targetable ‼️

My selection of the 4 pictures allowed in X here 📸

ESMO - Eur. Oncology

No significant OS difference in gem/cis/nab-paclitaxel vs. gem/cis SWOG Cancer Research Network 1815 advanced #biliarycancer Rachna Shroff, MD, FASCO #GI23 ASCO OncoAlert Cure GI Cancers 31% vs. 22% ORR (NS)
For gallbladder: mOS 17 vs. 9.3 months, ORR 44% vs. 22%

Hear expert guidance on battling advanced #BiliaryTractCancers at #GI24 on January 18th at 5:15 PM PST. Featuring experts Milind Javle, @GIcancerdoc, & Rachna Shroff, MD, FASCO! Developed with our partners, Cholangiocarcinoma Foundation. bit.ly/BiliarySF24T #BiliaryCancer #Oncology #MedEd #MedTwitter

Register ASAP for this January 18th #BiliaryCancer #MedEd Symposium at 5:15 PM PST during #GI24 ! With Drs. Milind Javle (Milind Javle), Tanios Bekaii-Saab (@GIcancerdoc) & Rachna Shroff (@rachnatshroff) & developed with Cholangiocarcinoma Foundation! bit.ly/BiliarySF24T #Oncology #MedTwitter

Join #BiliaryCancer experts, Milind Javle, MD (Milind Javle), Tanios Bekaii-Saab, MD (@GIcancerdoc), & Rachna Shroff, MD, MS, FASCO (@rachnatshroff) on 1/18 at 5:15 PM PST during #GI24 for a live #MedEd symposium! Produced with Cholangiocarcinoma Foundation: bit.ly/BiliarySF24T #Oncology

.Ruth He, MD, PhD presenting results of her phase II olaparib/pembrolizumab study in advanced #biliarycancer #DAVABermudaGI Cure GI Cancers

Learn strategies to develop individualized treatment plans for your patients with advanced BTCs on January 18th at 5:15 PM PST during #GI24 , with experts Milind Javle, @GIcancerdoc, & Rachna Shroff, MD, FASCO, and our partner, Cholangiocarcinoma Foundation! bit.ly/BiliarySF24T #MedEd #BiliaryCancer

Nutide-121 in #WCGIC2023 shows NO benefit of NUC-1032 in #BiliaryCancer

😕 Dissapointing results, but a very important study

🤷🏻‍♀️Rational was there and had to be tested

✍️Highlights the relevance of performing randomised studies (when feasible 😉)